Latest Conference Articles

Nicholas Popovich, Phd, Associate Dean of Professional Development at the University of Illinois, is the recipient of the American Association of Colleges of Pharmacy (AACP) 2017 Lifetime Achievement Award.

In this clip, Ron Jordan, RPh, FAPhA, Dean of Chapman University School of Pharmacy, gives his take on the future job outlook for pharmacists and how jobs in pharmacy are changing.

Wilson M. Compton, MD, MPE, Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health, addressed pharmacists about their roles in curbing the opioid crisis at the American Association of Colleges of Pharmacy (AACP) annual meeting.

Lucinda Maine, Phd, RPh, Executive Vice President and CEO of the American Association of Colleges of Pharmacy (AACP), discusses how pharmacists can promote the value of the profession to their patients and the public.

Nicholas Popovich, Phd, Associate Dean of Professional Development at the University of Illinois, is the recipient of the American Association of Colleges of Pharmacy (AACP) 2017 Lifetime Achievement Award. In this clip, Dr. Popovich offers advice to recent graduates and new pharmacists embarking on their careers.

In this clip, Stefanie Ferreri, PharmD, clinical professor at UNC Eshelman School of Pharmacy, talks about how community pharmacists can work to advance the profession and change how community pharmacy is portrayed.

In this clip, Melissa Hogan, PharmD, Dean of Roosevelt University College of Pharmacy, shares some advice for pharmacy students and pharmacy school graduates on how to stand out to employers in the job market.

Throughout his career, Brian Nightengale, PhD, has bared witness to many of the changes and challenges experienced by independent pharmacists.

Results of 2017 Kantar Media Readership Survey demonstrate publication's ongoing valuable leadership among retail pharmacists.

Few students when they graduate from pharmacy school have had little exposure to veterinary medications.

When palliative care is involved, they address the physical, as well as psychosocial symptoms, to improve quality of life.

The American Association of Colleges of Pharmacy (AACP) has announced that Senior Director of Academic Affairs Cecilia M. Plaza, PharmD, PhD, is the first pharmacist chosen to participate in the ASAE Diversity Executive Leadership Program (DELP) as a Scholar for 2017-2019.

As independent pharmacy continues to evolve, pharmacy owners face both a potential for growth and obstacles to overcome to enable that growth.

The American Association of Colleges of Pharmacy (AACP) is holding its annual meeting from July 15-19, in Nashville, Tennessee.

Independent pharmacists have emerged as trusted advisors who play an increasingly important role in community care nationwide.

Pharmacy Times and Parata Systems, founding partners of the Next-Generation Pharmacist awards, have announced this year’s 30 finalists.

Closed-loop systems help diabetes patients achieve blood glucose control, according to a presentation at the American Diabetes Association’s 77th Scientific Sessions.

Transition care may improve diabetes outcomes, according to a study presented at the American Diabetes Association’s 77th Scientific Sessions.

American Diabetes Association’s 77th Scientific Sessions highlight benefits of glucose monitoring.

Adolescents and young adults with type 1 diabetes benefit from a structured transition program when changing from pediatric to adult diabetes care.

These data, from the integrated analysis of the CANVAS and CANVAS-R trials, demonstrated the CV safety of canagliflozin (P

According to information on the conference website, ThoughtSpot gives independent community pharmacies practical information in growing their business goals and revenue through education sessions, while also providing opportunities for exclusive deals on product purchases at the show.

Results of this trial were presented at the ADA Meeting in San Diego.

REMOVAL trial results presented at the American Diabetes Association’s 77th Scientific Sessions.

Results of the ODYSSEY study presented at the American Diabetes Association’s 77th Scientific Sessions.

Metformin may be an effective long-term strategy worthy of adding to an individual’s diabetes care plan to reduce the risk of heart disease in adults with type 1 diabetes.

Sotagliflozin effective in treating patients with type 1 diabetes.

Findings presented at ADA conference highlight effiacy of insulin glargine/lixisenatide combination.

The results of the ODYSSEY-Diabetes trials focused on alirocumab, an approved monoclonal antibody that prevents PCSK-9 protein from impairing the liver’s receptors, and that antibody's effect on type 2 diabetes (T2D).